Viewing StudyNCT03214250



Ignite Creation Date: 2024-05-06 @ 10:18 AM
Last Modification Date: 2024-10-26 @ 12:27 PM
Study NCT ID: NCT03214250
Status: COMPLETED
Last Update Posted: 2022-12-23
First Post: 2017-06-09

Brief Title: Safety and Efficacy of APX005M With Gemcitabine and Nab-Paclitaxel With or Without Nivolumab in Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma
Sponsor:
Organization: Parker Institute for Cancer Immunotherapy